Tag: DelveInsight

Snippet

Snippets

Read More

Predicting risk of Acute Myeloid Leukemia (AML) in healthy individuals

Articles, Business Consultant, Pharma Consultant

The occurrence of acute myeloid leukemia (AML) keeps on increasing with age and mortality surpasses 90% if diagnosed after age of 65. Most...

Read More

Notizia

Business Consultant, Notizia, Pharma Consultant

Arming antibiotics with a vaccination-like immune response Harnessing the ability of the body’s immune system has...

Read More

Fatty Acid Amide Hydrolase (FAAH) Inhibitor – an enzyme with novel therapeutic potential

Articles, Business Consultant, Pharma Consultant

Fatty acid amide hydrolase (FAAH) belongs to the serine hydrolase family of enzymes. The identification of this enzyme was led by the...

Read More

Hepatic Encephalopathy- An ailment of liver to brain

Articles

Hepatic Encephalopathy (HE) can be described as deterioration of brain function occurring due to accumulation of toxic substances in the...

Read More

Notizia

Notizia, Pharma Consultant

Idera’s dermatomyositis drug missed primary endpoint in phase 2 Idera’s toll-like receptor (TLR) antagonist, IMO-8400, failed to...

Read More

Notizia

Business Consultant, Notizia, Pharma Consultant

Axovant rely on new gene therapy, Rise in Shares  Roivant Neuro Company has licensed Oxford Biomedica’s gene therapy OXB-102, now...

Read More
Close